Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples